Navigation Links
Ventas to Present at the Citi 2008 Global Property CEO Conference
Date:2/26/2008

LOUISVILLE, Ky., Feb. 26 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that its Chairman, President and Chief Executive Officer, Debra A. Cafaro, and Executive Vice President and Chief Investment Officer, Raymond J. Lewis, will make a presentation regarding the Company at the Citi 2008 Global Property CEO Conference in Palm Beach, Florida on Tuesday, March 4, 2008 at 1:15 p.m. Eastern Time.

Those wishing to access the presentation may dial in to the conference at 719-234-7878, passcode: 394890. Any written materials accompanying the presentation will be available on the Company's website at http://www.ventasreit.com at the time of the presentation and for one month thereafter.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43 states and two Canadian provinces includes seniors housing communities, skilled nursing facilities, hospitals and medical office and other properties. More information about Ventas can be found on its website at http://www.ventasreit.com.

Contacts: Debra A. Cafaro

Chairman, President and CEO

or

Richard A. Schweinhart

Executive Vice President and CFO

(502) 357-9000


'/>"/>
SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
2. Ventas Completes Previously Announced Sale of Common Stock
3. Ventas Enters Agreement to Sell Common Stock
4. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
5. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
6. Ventas Appoints Brush SVP - Senior Housing Development and Operations
7. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
8. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
9. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
10. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
11. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... agency which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating ... lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone ...
(Date:1/19/2017)... , ... January 18, 2017 , ... The CHP suggests ... during a rain storm by slowing down and increasing the space between themselves and ... Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or shine, ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... styled text designs that will simplify the editing process for all media productions," ... Basics is a package of 30 simplistically styled self-animating paragraphs designed for multi-lined ...
(Date:1/18/2017)... Austin, TX (PRWEB) , ... January 18, 2017 , ... ... million people opened a global discussion about the benefits of fidgeting to relieve stress ... Lyon and Jym Daniel. Their Think Ink Pen had just completed a successful ...
(Date:1/18/2017)... SAN JOSE, Calif, USA; and SHANGHAI, China – , ... ... January 18, 2017 -- Global public health organization NSF International ... V (pentavalent arsenic) to NSF/ANSI 53: Drinking Water Treatment Units ... treatment units. This certification verifies that MicroCeramics’ NanoNose Pitcher Filter ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017  EnteroMedics Inc. (NASDAQ: ETRM ... technology to treat obesity, metabolic diseases and other ... underwritten public offering of units for gross proceeds ... and commissions and offering expenses payable by EnteroMedics. ... A Units, priced at a public offering price ...
(Date:1/18/2017)...  Adaptive Sound Technologies, Inc. (ASTI), the leading supplier ... Hyatt Place Nashville/Downtown to deliver the best sleep experience ... machines in over two hundred of its guest rooms. ... of having a great stay is sleeping well," said ... Nashville/Downtown. "We,re pleased to be able to offer our ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
Breaking Medicine Technology: